Difficulty: Medium
Average Score: 69%
Practice
Select the antibiotic whose dose must be reduced in patients with renal insufficiency
Correct answer
C
Rationale
In the context of pharmacology and patient care, it is crucial to understand how different antibiotics are metabolized and excreted from the body, particularly in patients with renal insufficiency. The correct answer to this question is option C) Tobramycin.
Tobramycin is primarily eliminated through the kidneys, and in patients with renal insufficiency, its clearance is reduced. Therefore, to prevent potential toxicity, the dose of Tobramycin must be adjusted or reduced in these patients. This is due to the risk of drug accumulation and subsequent adverse effects, such as nephrotoxicity and ototoxicity.
Regarding the other options:
A) Ampicillin is primarily excreted through the kidneys, but dose adjustments are not as critical as with Tobramycin in renal insufficiency.
B) Chloramphenicol is primarily metabolized in the liver and excreted in the bile, so renal function does not significantly impact its clearance.
D) Erythromycin is metabolized in the liver and excreted in bile, so its dose does not need to be reduced in renal insufficiency.
Understanding the principles of antibiotic pharmacokinetics in relation to renal function is essential for healthcare professionals to ensure safe and effective treatment for their patients. It highlights the importance of individualized dosing based on a patient's renal function to avoid adverse drug reactions and optimize therapeutic outcomes.
Tobramycin is primarily eliminated through the kidneys, and in patients with renal insufficiency, its clearance is reduced. Therefore, to prevent potential toxicity, the dose of Tobramycin must be adjusted or reduced in these patients. This is due to the risk of drug accumulation and subsequent adverse effects, such as nephrotoxicity and ototoxicity.
Regarding the other options:
A) Ampicillin is primarily excreted through the kidneys, but dose adjustments are not as critical as with Tobramycin in renal insufficiency.
B) Chloramphenicol is primarily metabolized in the liver and excreted in the bile, so renal function does not significantly impact its clearance.
D) Erythromycin is metabolized in the liver and excreted in bile, so its dose does not need to be reduced in renal insufficiency.
Understanding the principles of antibiotic pharmacokinetics in relation to renal function is essential for healthcare professionals to ensure safe and effective treatment for their patients. It highlights the importance of individualized dosing based on a patient's renal function to avoid adverse drug reactions and optimize therapeutic outcomes.